Asianet Newsable on MSN
VKTX stock slides overnight after Q3 loss: CEO’s obesity drug launch timeline frustrates retail
CEO Brian Lian said a potential launch of obesity drug VK2735 remained about 2 and a half years away.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results